ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OPTI Optibiotix Health Plc

16.00
0.25 (1.59%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.59% 16.00 15.50 16.50 16.00 15.75 15.75 318,594 15:50:52
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.63 14.59M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 15.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £14.59 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.63.

Optibiotix Health Share Discussion Threads

Showing 49701 to 49722 of 147775 messages
Chat Pages: Latest  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  Older
DateSubjectAuthorDiscuss
01/3/2019
14:53
Yes, as I said. Scientifically way ahead.
imnotlong
01/3/2019
14:52
I am sure Sweetbiotix will be commercialised in due course. Failure to do so would be a very large red flag; however, I expect it will and hopefully we will hear something fairly soon.
rafboy
01/3/2019
14:50
I remember this line from the Probiota poster:Whilst our previous studies have demonstrated that these fibres have high sweetness and no aftertaste, this is the FIRST STUDY TO OUR KNOWLEDGE of a high intensity sweetener demonstrating a POSITIVE EFFECT on the microbiome.
parob
01/3/2019
14:48
Yes Parob, it is. I just hope Opti are not left commercially behind, even with the appointment of Fred. They are clearly ahead scientifically.

I rembember this line on Sweetbiotix way back from the November 2016 financial report, page 6 (published in 2017).

“In anticipation of growing industry interest, we have accelerated our development plans and hope to launch our first generation sugar product later this year, or at the start of 2018”.

imnotlong
01/3/2019
14:46
When you look at what these corporates are doing in this area & then at sweetbiotix the novelty is in a completely different league. No wonder SOH said Sweetbiotix is well ahead of the curve after speaking with the majors in this space. Sugars will be the golden egg.
riskybusiness1
01/3/2019
14:43
Just goes to show what Opti are up against?!
rayrac
01/3/2019
14:29
Yes that's been in the offing since late last year imnotlong. Goes to show which way the industry is heading.
parob
01/3/2019
14:23
DSM have just announced the start of Avansya, their sugar replacement JV with Cargill.
imnotlong
01/3/2019
14:09
Let’s hope a decent RNS arrives next week. It needs something to change this annoying and repetitive trading range.
imnotlong
01/3/2019
14:00
Rath definitely no ingredients supplier, that's a huge misunderstanding. Sacco are an ingredient supplier. That's the top of the revenue chain for Opti.Do not forget the milestones the US will pay before launch over 7 figures & another 7 figures if they want global exclusivity before launch. Phase 1 & 2 data already collected. FDA GRAS will speed up the biopharma development. SOH said the US pharma had ambition to launch within 3 years. By that time the current distribution deals that are definitely not 'MOU' will have established recurring & growing revenues streams across the divisions.Once LPLDL goes in to dairy & a few multi million £ deals come from India along with TATA big rerate to come if all plays out like it looks like it will.
riskybusiness1
01/3/2019
13:50
Another tick down by the looks of things as sell coming in below bid,didn't think we'd get down here again.
scotty1
01/3/2019
13:49
What is it with the selling today! Despite what Raythean has written, I believe we are far closer to a decent rerate. Quite possible over the next few months.
rafboy
01/3/2019
13:45
LP-LDL being recognised by another industry expert in this article. The word is definitely getting out there: hTTps://www.deliciousliving.com/health/a-numbers-game/
parob
01/3/2019
13:38
I think OPTI is a good few years from that. Stick these in an ISA and come back in 3 years, the business might have caught up with its current valuation.The pharma discussion is for a long way into the future, otherwise it's an ingredients supplier with lots of as yet revenue less MoUs that may or may not amount to something... all imo dyor ofc.
rathean
01/3/2019
09:53
Like most new technologies (ref ARM) takes years, building the IP,trust, agreeing distribution, licenses etc. Then all of a sudden the tech was/is in everything. Feels familiar to me.
Our problem is that we are close to Opti, follow its every move. Switch off and drop back in 1 yrs time and you may well see the transformational change in proliferation/customer base and ultimately earnings, that we all seek.
We really are getting close now, mark my words

pol123
01/3/2019
08:50
Ramp ramp ramping along see how the lies do fly. All the way from India!
rayrac
01/3/2019
08:42
Lol

Guys there’s links all over the place now showing big corporates followignornliking news from Opti.

Arla, nestle, we are due news according to soh from big US corporates that were waiting for gras sign off.

shrewdmole
01/3/2019
08:32
Do you mean they are in a tuk tuk tailing them around India?
imnotlong
01/3/2019
08:18
Nestle India following Opti.....
shrewdmole
01/3/2019
07:47
Completely agree Parob, once the term Microbiome and its modulation to create health benefits are as widely recognised by the general public as, say, probiotics, then OPTI will really come into its own
trotterstrading
01/3/2019
07:37
So 62 orders in 7 days, which is a big increase from the average of 4 a day during early Feb. It seems the adverts are working...
nobbygnome
01/3/2019
07:25
Placed an order last night of Cholbiome - number 1751 for anyone keeping track!
primal123
Chat Pages: Latest  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  Older